Title: Precision Medicine for Cancer: A Perspective

Abstract:

Precision medicine is rapidly gaining attention as a potential approach to therapeutics to oppose the conventional “one‐size‐fits‐all” approach of classical pharmacotherapy. Conventional approaches suffer from lack of efficacy, and ignore the heterogeneous nature of diseases and the variations among individuals’ genetic make-up. Precision medicine aims to categorize individuals into subclasses on the basis of differences in their predisposition to a particular disease.  

Precision medicine uses majorly genetic biomarkers along with personal data to design treatments for classified individuals as mentioned above. Precision medicine has two protagonists, namely pharmacogenetics and genomic medicine. Genomic medicine is based on analyzing the polymorphic variations among the sequences of individuals’ DNA, and using the same to predict the efficacy and harmful side-effects of any targeted therapeutics. Pharmacogenetics is the tailor-made synthesis of pharmaceuticals based on available genetic information.

Biography:

Dr. Shampa Sen is the founder of Edumatter, an online platform for guiding and mentoring students of engineering and science. She completed her Ph.D. in Environment from Indian Institute of Technology, Guwahati, India, and is a former Associate Professor of School of Bio Sciences and Technology, VIT, Vellore. At present, she is also a Guest Lecturer at the esteemed Department of Chemical Technology, University of Calcutta. With extensive experience in academia, she has more than 90 publications in the fields of biotechnology, drug design, nanobiotechnology and nutraceuticals